COLUMVI Concentrate for solution for infusion Ref.[51062] Active ingredients: Glofitamab

Source: European Medicines Agency (EU)  Revision Year: 2023  Publisher: Roche Registration GmbH, Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany

Product name and form

Columvi 2.5 mg concentrate for solution for infusion.

Columvi 10 mg concentrate for solution for infusion.

Pharmaceutical Form

Concentrate for solution for infusion (sterile concentrate).

Colourless, clear solution with a pH of 5.5 and osmolality of 270-350 mOsmol/kg.

Qualitative and quantitative composition

Columvi 2.5 mg concentrate for solution for infusion: Each vial of 2.5 mL of concentrate contains 2.5 mg of glofitamab at a concentration of 1 mg/mL.

Columvi 10 mg concentrate for solution for infusion: Each vial of 10 mL of concentrate contains 10 mg of glofitamab at a concentration of 1 mg/mL.

Glofitamab is a humanised anti-CD20/anti-CD3 bispecific monoclonal antibody produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Glofitamab

Glofitamab is a bispecific monoclonal antibody that binds bivalently to CD20 expressed on the surface of B cells and monovalently to CD3 in the T-cell receptor complex expressed on the surface of T cells. By simultaneous binding to CD20 on the B cell and CD3 on the T cell, glofitamab mediates the formation of an immunological synapse with subsequent T-cell activation and proliferation, secretion of cytokines and release of cytolytic proteins that results in the lysis of CD20-expressing B cells.

List of Excipients

L-histidine
L-histidine hydrochloride monohydrate
L-methionine
Sucrose
Polysorbate 20 (E432)
Water for injections

Pack sizes and marketing

Columvi 2.5 mg concentrate for solution for infusion:

2.5 mL concentrate for solution for infusion in a 6 mL vial (colourless Type I glass) with stopper (butyl rubber).

Pack size of 1 vial.

Columvi 10 mg concentrate for solution for infusion:

10 mL concentrate for solution for infusion in a 15 mL vial (colourless Type I glass) with stopper (butyl rubber).

Pack size of 1 vial.

Marketing authorization holder

Roche Registration GmbH, Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany

Marketing authorization dates and numbers

EU/1/23/1742/001
EU/1/23/1742/002

Drugs

Drug Countries
COLUMVI Austria, Canada, Estonia, France, Croatia, Ireland, Israel, Lithuania, Romania, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.